Trials / Completed
CompletedNCT00845481
A Plaque Test Comparing the Anti-psoriatic Effect of Marketed Products for Topical Use for Psoriasis Vulgaris
A Plaque Test Comparing 4 Steroids With Daivobet® Ointment and a Vehicle Control for the Treatment of Psoriasis Vulgaris
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to compare the anti-psoriatic effect of marketed products with Daivobet® ointment in a plaque test
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Daivobet® ointment | Once daily application 6 days a week for 3 weeks |
| DRUG | Betnovat® ointment | Once daily application 6 days a week for 3 weeks |
| DRUG | Diprosalic ointment | Once daily application 6 days a week for 3 weeks |
| DRUG | Dermovat ointment | Once daily application 6 days a week for 3 weeks |
| DRUG | Elocon ointment | Once daily application 6 days a week for 3 weeks |
| DRUG | Daivobet® ointment vehicle | Once daily application 6 days a week for 3 weeks |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2009-03-01
- Completion
- 2009-05-01
- First posted
- 2009-02-18
- Last updated
- 2025-03-12
- Results posted
- 2011-03-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00845481. Inclusion in this directory is not an endorsement.